Xinru Chen
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Best evidence for the prevention and management of anastomotic fistula after esophagectomy in patients with esophageal cancer.
Journal: Asia-Pacific journal of oncology nursing
Published: November 16, 2025
FAK activation drives non-genetic adaptive survival of ALK-rearranged lung cancer under tyrosine kinase inhibitor treatment.
Journal: Journal of genetics and genomics = Yi chuan xue bao
Published: October 26, 2025
The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor.
Journal: Translational oncology
Published: November 05, 2021
Utility of comprehensive genomic profiling in directing treatment and improving patient outcomes in advanced non-small cell lung cancer.
Journal: BMC medicine
Published: May 22, 2021
Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysis.
Journal: Journal for immunotherapy of cancer
Published: July 24, 2020
Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.
Journal: Oncogene
Published: July 23, 2020
Clinical benefit of continuing crizotinib therapy after initial disease progression in Chinese patients with advanced ALK-rearranged non-small-cell lung cancer.
Journal: Oncotarget
Published: October 20, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026